Spyre Therapeutics Inc <SYRE.O>: Baird assumes coverage with outperform rating; target price $120
SYRE•Related News
Faraday Future hosts “Built in USA” partner recruitment conferences for robotics push
FFAI•
Nestle looks to develop new products to serve users of weight-loss drugs
NSRGY•
Hawaiian Electric crews restore power to nearly 180,000 customers
HE•
GRAINS-Wheat extends rally as Black Sea risks, US dryness support prices
DBA•